RSNA 2022: MRI for colorectal cancer metastases | Dark-field x-ray effectively stages pulmonary emphysema | Virtual or in-person RSNA attendance?

CHICAGO - Although still not close to prepandemic levels, attendance at the RSNA meeting continues to rebound.

The RSNA has announced that it expects 30,907 in-person attendees in Chicago, including 16,045 professionals. Overall, total advance registration was 34,385, including 19,485 professionals.

Although still well off the final attendance of 52,000 in 2019 prior to COVID, those estimates are still up sharply from the 19,000 in-person attendees that were expected in Chicago before the 2021 RSNA meeting. Ultimately, the final attendee count for last year's conference was 29,273, including just over 23,000 onsite at McCormick Place.

RSNA 2022 conference is already in full swing, both in the exhibit hall and in the presentation rooms. Check our coverage so far from Day 1, including an article on how MRI appears to be the most cost-effective way for diagnosing colorectal cancer liver metastases and a story on how dark-field x-ray compares with conventional radiography for diagnosing and staging pulmonary emphysema. In addition, Michael J. Cannavo, aka the PACSman, shares his perspective on the pros and cons of in-person versus virtual attendance at the RSNA meeting.

The editorial team will be in Chicago all week filing reports on the latest research and product introductions. Be sure to check out our RADCast @ RSNA for the latest news, and you can also follow us on Twitter for even faster updates.

Page 1 of 22
Next Page